Rivastigmine is an acetylcholinesterase (AchE) and butyrylcholinesterase (BchE) inhibitor
drug approved by the US Food and Drug Administration (FDA) for the treatment of mild to …

In this work, sucrose acetate isobutyrate (SAIB) and polylactic co-glycolic acid (PLGA) were
used alone or in combination as a matrix-former (MF) to prepare long-acting injectable …

The main aim of the investigation was to explore a novel L-lactide-depsipeptide copolymer
for the development of rivastigmine-loaded polymeric nanoparticles. L-lactide-depsipeptide …

The aim of the present study is to prepare risperidone-loaded poly lactic-co-glycolic acid
(PLGA) microspheres within microfluidic system and to achieve a formulation with uniform …

The purpose of this study was to investigate the influences of drying methods on the
risperidone (RIS) release profiles of RIS-loaded PLGA microspheres. These microspheres …

To develop a long-acting injectable thienorphine biodegradable poly (d, l-lactide-co-
glycolide)(PLGA) microsphere for the therapy of opioid addiction, the effects of formulation …

The aim of this study was to fabricate different risperidone (RIS)–loaded poly (lactic‐co‐
glycolic acid) microspheres (PLGA MS) with various viscosity of PLGA polymers and …

Background: A long release period lasting several days or several weeks is always needed
and thereby it is tedious and time consuming to screen formulations of such microspheres …

Huperzine A-loaded microspheres composed of poly (D, L-lactide-co-glycolide) were
prepared by an O/W emulsion solvent evaporation method. The characterization of the …

The aim of this study was to design and evaluate biodegradable PLGA microspheres for
sustained delivery of Risperidone, with an eventual goal of avoiding combination therapy for …